Key takeaways:
Xywav is FDA-approved to treat certain sleep disorders, such as narcolepsy and idiopathic hypersomnia (IH), in adults. It’s the only FDA-approved medication for IH.
Though it’s not exactly clear how Xywav works to treat IH, its active ingredient oxybate is thought to calm the brain and promote better sleep.
Xywav can lead to dependence and misuse, which is why it’s a controlled substance. It can also slow your breathing, especially if it’s used in combination with other sleep medications, opioids, or benzodiazepines. Make sure your healthcare professional and pharmacist have an updated list of your medications (both over-the-counter and prescription) before starting Xywav.
Idiopathic hypersomnia (IH) is a rare sleep disorder that causes extreme sleepiness during the day, even after you’ve gotten a full night’s sleep. People with IH may sleep 9 hours or more per night but still wake up feeling as if they haven’t slept at all. IH also causes sleep inertia, or “sleep drunkenness,” making it difficult to get out of bed. Even long naps often aren’t refreshing for people with IH. But with IH, there’s no clear reason for the sleepiness — that’s why it’s called “idiopathic.”
In August 2021, the FDA approved Xywav as a treatment option for IH. In fact, it’s the only medication that’s FDA-approved for this condition. Here, we’ll discuss how Xywav works for IH, how it compares to other IH medications, and more.
Xywav is an oral liquid solution containing a mixture of four active ingredients. They’re each a form of oxybate salt:
Calcium oxybate
Magnesium oxybate
Potassium oxybate
Sodium oxybate
The active molecule in Xywav is oxybate, a central nervous system depressant. This means it slows your brain function. More specifically, oxybate is related to a chemical messenger in the body called gamma-aminobutyric acid (GABA). GABA decreases nerve cell activity, so it has a calming effect on the brain and body. When you take medication containing oxybate, it boosts the effects of GABA.
It’s not completely understood how Xywav works to treat IH. But experts think that while you’re sleeping, greater GABA activity in certain parts of your brain promotes better quality sleep, so you wake up feeling more rested.
Xywav was originally FDA-approved in 2002 to treat excessive daytime sleepiness (EDS) and cataplexy (sudden muscle weakness triggered by strong emotions) in people at least 7 years old who have narcolepsy. It became FDA-approved for IH in adults in 2021.
Xywav is unique because it’s the only medication that’s specifically FDA-approved for IH. Other medications, such as Provigil (modafinil), are also recommended for IH, but they’re used off-label. Off-label use is when a medication is prescribed for a condition for which it’s not FDA-approved.
Yes. Xywav is a controlled substance. This means it has a risk for dependency and misuse.
As mentioned above, the active ingredient in Xywav is oxybate — the salt form of a substance called gamma-hydroxybutyrate (GHB). GHB is an illegal drug that can calm the body and produce a “high.” GHB has the potential to cause dependency and be misused.
When Xywav is taken as prescribed, it’s considered safe. But since it’s related to GHB, it has risks, too, especially when used incorrectly. Some risks can be life-threatening, including slowed breathing, seizures, and coma.
Serious risks are why Xywav can only be prescribed and dispensed under a Risk Evaluation and Mitigation Strategies (REMS) program. This means there are special requirements put in place by the federal government to monitor and control how Xywav is prescribed and used. For example, only certified healthcare professionals (HCPs) can prescribe Xywav. And only certified pharmacies can dispense it.
The American Academy of Sleep Medicine (AASM) has guidelines for treating sleep disorders including IH. According to AASM, Provigil is the first-choice medication for treating IH. Provigil is recommended over other medications for most people because we have more research on its use in IH. But it’s important to note that the AASM guidelines were developed before Xywav was FDA-approved for IH. Larger, better designed studies of Xywav show it may improve more symptoms of IH than separate studies of Provigil found. Notably, people taking Xywav reported improvements in sleep inertia and daytime functioning.
However, other medications can also treat IH and may even be better options for some people. Other medications besides Xywav to treat IH include:
Xyrem (sodium oxybate)
Clarithromycin
Ritalin (methylphenidate)
Wakix (pitolisant)
You may notice that Xyrem contains sodium oxybate, just like Xywav does. We don’t have any studies comparing Xywav with Xyrem at this time. But because they both contain the same active molecule oxybate, they’re expected to work just as well for IH. There are differences, though. The major differences between these two medications are:
Xywav contains 92% less sodium than Xyrem at approved doses. While they both contain the same amount of oxybate, Xywav contains a mixture of oxybate salts, instead of just sodium. So Xywav may be preferred in people with conditions where consuming too much sodium can be problematic, such as heart failure, high blood pressure, and kidney problems.
Only Xywav is FDA-approved for IH. But Xyrem may still be used off-label for this condition.
When taken under the care of a medical professional trained to prescribe Xywav, it’s considered safe for many people. However, like all medications, it has possible risks. Possible Xywav side effects may include:
Nausea and vomiting
Headache
Increased sweating
Decreased appetite
Dizziness
Parasomnia (such as sleepwalking)
Tremor (shakiness)
Trouble sleeping
Dry mouth
Diarrhea
Anxiety
More serious risks are also possible, including:
Dependence and misuse
Slowed breathing, especially in people who take other medications or substances that slow brain function (such as alcohol, opioids, benzodiazepines, and other sleep medications)
Excessive drowsiness, making it unsafe to drive or difficult to complete other daily tasks
Sleep apnea, as well as other sleep-related breathing problems, which can be especially likely in people who already have apnea
Sleep-related behaviors, such as sleepwalking, which may cause injuries
Mental health side effects, including hallucinations, depression, and suicidal thoughts (The risk is greater if you have existing depression, or a history of depression and suicidal thoughts or actions.)
Avoid driving or operating machinery for at least 6 hours after taking Xywav. But when you first start taking Xywav, it’s a good idea to be even more cautious until you know how it affects you. And if you experience excessive drowsiness, sleepwalking, or changes in your mood while taking Xywav, contact your HCP immediately.
If you or someone you know is having thoughts of suicide, you’re not alone, and help is available. Call the National Suicide Prevention Lifeline at 988, or text HOME to 741-741 to reach the Crisis Text Line.
Good to know: Xywax can interact with other medications. For example, Xywav shouldn’t be used with other sleep medications, because the combination increases your risk of slowed breathing. Examples include zolpidem (Ambien) and eszopiclone (Lunesta), among others. Before starting Xywav, give your HCP and pharmacist a list of all the medications and over-the-counter products you take. This will help them check for interactions.
Xywav is the only FDA-approved medication for treating idiopathic hypersomnia (IH). It also treats narcolepsy. Xywav contains four oxybate salts (calcium, magnesium, potassium, and sodium). It’s not exactly clear how Xywav works to treat IH, but it’s thought that oxybate calms the brain and promotes better nighttime sleep so you feel less sleepy during waking hours.
Xywav can be safe and effective for IH, but it also has risks. Xywav is a controlled substance that can lead to dependence and misuse. It can also slow your breathing, especially if you take it with other sleep medications, opioids, or benzodiazepines. Give your healthcare professional and pharmacist an updated list of your over-the-counter and prescription medications before starting Xywav. This will help them check for drug interactions.
Arnulf, I., et al. (2023). Update on the treatment of idiopathic hypersomnia: Progress, challenges, and expert opinion. Sleep Medicine Reviews.
Bogan, R. K., et al. (2023). Long-term safety and tolerability during a clinical trial and open-label extension of low-sodium oxybate in participants with narcolepsy with cataplexy. CNS Drugs.
Busardò, F. P., et al. (2015). Clinical applications of sodium oxybate (GHB): From narcolepsy to alcohol withdrawal syndrome. European Review for Medical and Pharmacological Sciences.
Dauvilliers, Y., et al. (2022). Calcium, magnesium, potassium, and sodium oxybates oral solution: A lower-sodium alternative for cataplexy or excessive daytime sleepiness associated with narcolepsy. Nature and Science of Sleep.
Heo, Y.-A. (2022). Calcium, magnesium, potassium and sodium oxybates (Xywav) in sleep disorders: A profile of its use. CNS Drugs.
Hypersomnia Foundation. (2024). Idiopathic hypersomnia.
Jazz Pharmaceuticals Inc. (2020). Jazz Pharmaceuticals announces U.S. FDA approval of Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution for cataplexy or excessive daytime sleepiness associated with narcolepsy.
Jazz Pharmaceuticals, Inc. (2023). Xywav- (calcium, magnesium, potassium, and sodium oxybates) solution [package insert].
Jewett, B. E., et al. (2023). Physiology, GABA. StatPearls.
Maski, K., et al. (2021). Treatment of central disorders of hypersomnolence: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine.
Schneider, L. D., et al. (2023). Long-term treatment of narcolepsy and idiopathic hypersomnia with low-sodium oxybate. Nature and Science of Sleep.
U.S. Department of Justice/Drug Enforcement Administration. (2022). What is GHB?
U.S. Food & Drug Administration. (2021). FDA grants first of its kind indication for chronic sleep disorder treatment.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.